Nativis Secures $2,319,301 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    219 Terry Avenue North Seattle, WA 98109 USA
  • Company Description
    Natvis Voyager is a medical device that replaces standard chemotherapy with specific low level radio frequency energy (REF).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy